Clinical Trial Update: Phase 2 Study of Yimitasvir Phosphate Capsules [Phase 2]

View source ↗

Summary

Phase 2 study of Yimitasvir Phosphate Capsules for chronic hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Yimitasvir Phosphate Capsules (Yimitasvir phosphate)

Snippet

Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Chronic HCV Infection | Phase 2 | Status: COMPLETED